Evoke Pharma, Inc.

Evoke Pharma, Inc.verified

EVOK

Price:

$5.6527

Market Cap:

$4.63M

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2013-09-25

Stock Exchange

NASDAQ

Ticker

EVOK

The PE Ratio as of November 2024 (TTM) for Evoke Pharma, Inc. (EVOK) is -0.36

According to Evoke Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.36. This represents a change of -92.12% compared to the average of -4.57 of the last 4 quarters.

Evoke Pharma, Inc. (EVOK) Historical PE Ratio (quarterly & annually)

How has EVOK PE Ratio performed in the past?

The mean historical PE Ratio of Evoke Pharma, Inc. over the last ten years is -33.49. The current -0.36 PE Ratio has changed 7.51% with respect to the historical average. Over the past ten years (40 quarters), EVOK's PE Ratio was at its highest in in the September 2024 quarter at -1.27. The PE Ratio was at its lowest in in the December 2017 quarter at -337.96.

Quarterly (TTM)
Annual

Average

-33.49

Median

-27.89

Minimum

-65.33

Maximum

-5.41

Evoke Pharma, Inc. (EVOK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Evoke Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 97.66%

Maximum Annual PE Ratio = -5.41

Minimum Annual Increase = -60.47%

Minimum Annual PE Ratio = -65.33

Quarterly (TTM)
Annual
YearPE RatioChange
2023-5.41-56.36%
2022-12.39-47.37%
2021-23.53-60.47%
2020-59.54-2.56%
2019-61.10-6.48%
2018-65.3397.66%
2017-33.0556.88%
2016-21.07-0.61%
2015-21.20-34.28%
2014-32.25-56.80%

Evoke Pharma, Inc. (EVOK) Average PE Ratio

How has EVOK PE Ratio performed in the past?

The current PE Ratio of Evoke Pharma, Inc. (EVOK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-13.78

5-year avg

-32.39

10-year avg

-33.49

Evoke Pharma, Inc. (EVOK) PE Ratio vs. Peers

How is EVOK’s PE Ratio compared to its peers?

Evoke Pharma, Inc.’s PE Ratio is less than Petros Pharmaceuticals, Inc. (-0.18), greater than Cumberland Pharmaceuticals Inc. (-1.56), greater than Agile Therapeutics, Inc. (-0.65), less than PainReform Ltd. (-0.12), greater than Aquestive Therapeutics, Inc. (-13.15), greater than Adamis Pharmaceuticals Corporation (-0.47), greater than Guardion Health Sciences, Inc. (-0.70), greater than AcelRx Pharmaceuticals, Inc. (-1.83), less than Eagle Pharmaceuticals, Inc. (0.31), greater than Regencell Bioscience Holdings Limited (-19.33), less than Procaps Group S.A. (4.80), greater than Incannex Healthcare Limited (-2.12), less than Journey Medical Corporation (135.43), greater than Jupiter Wellness, Inc. (-3.87), greater than Avadel Pharmaceuticals plc (-14.23), less than Biofrontera Inc. (-0.33), greater than Shuttle Pharmaceuticals Holdings, Inc. (-2.69), less than Akanda Corp. (-0.02), greater than China Pharma Holdings, Inc. (-0.83),

Build a custom stock screener for Evoke Pharma, Inc. (EVOK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evoke Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evoke Pharma, Inc. (EVOK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evoke Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Evoke Pharma, Inc.'s PE Ratio?

How is the PE Ratio calculated for Evoke Pharma, Inc. (EVOK)?

What is the highest PE Ratio for Evoke Pharma, Inc. (EVOK)?

What is the 3-year average PE Ratio for Evoke Pharma, Inc. (EVOK)?

What is the 5-year average PE Ratio for Evoke Pharma, Inc. (EVOK)?

How does the current PE Ratio for Evoke Pharma, Inc. (EVOK) compare to its historical average?